Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2021-09-23 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
普莱柯第四届董事会第十九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of 普莱柯生物工程股份有限公司. It details the convening of the fourth board's nineteenth meeting, the attendance, and the approval of several investment projects and the calling of an extraordinary shareholders meeting. The document does not contain financial statements or detailed financial data, nor is it a report or presentation. It is an announcement of board decisions, which fits the category of Board/Management Information (MANG). The document length is short and focused on board resolutions, not a full report or regulatory filing. Therefore, the classification is MANG with high confidence.
2021-09-23 Chinese
普莱柯关于召开2021年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about the convening of the 2021 first extraordinary general meeting (临时股东大会) of the company 普莱柯生物工程股份有限公司. It includes information about the meeting date, voting methods (on-site and online), agenda items to be voted on, shareholder eligibility, registration procedures, and an attached proxy authorization form. There is no financial data, earnings information, or report content. The document is clearly an announcement of a shareholders' meeting and related voting procedures, not the meeting materials or results themselves. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting and voting procedures rather than solicitation materials or voting results, it aligns best with Proxy Solicitation & Information Statement (PSI). The document length is under 5,000 characters, but it contains detailed meeting and voting information, not just a brief announcement, so it is not a Report Publication Announcement (RPA). Hence, the classification is PSI with high confidence.
2021-09-23 Chinese
普莱柯关于投资建设兽用灭活疫苗生产项目、生物制品车间改扩建项目的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a company regarding investment projects for vaccine production facilities. It details the investment amounts, project descriptions, risk factors, and approvals needed. It does not contain financial statements or detailed financial performance data, nor is it a transcript, audit report, or regulatory filing of financial results. The document is a formal announcement about capital investment projects, including funding sources and strategic rationale. It is not a report itself but an announcement of investment plans and related information. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is under 5,000 characters, but it contains substantive information about capital investment projects rather than just announcing a report publication or regulatory filing. Hence, CAP is the most appropriate classification with high confidence.
2021-09-23 Chinese
普莱柯关于股东减持超过1%的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a formal announcement regarding a shareholder's reduction of shareholding by more than 1%. It details the shareholder's name, the number of shares reduced, the percentage change in ownership, and confirms compliance with relevant securities laws. There is no financial data, earnings information, or management discussion. The content focuses on notifying the market about a significant shareholding change by a major shareholder. This fits the definition of a Major Shareholding Notification (MRQ). The document length is short and it is not an announcement of a report publication or a certification. Therefore, the correct classification is MRQ.
2021-08-11 Chinese
普莱柯第四届董事会第十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 17th meeting of the 4th Board of Directors of 普莱柯生物工程股份有限公司. It includes details about the meeting date, attendance, and voting results on two main agenda items: approval of the 2021 semi-annual report and adjustment of the company’s organizational structure. The document is not the semi-annual report itself but an announcement of the board meeting decisions, including approval of the report. It does not contain actual financial statements or detailed financial analysis, only a reference to the report on the stock exchange website. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management. The document length is short (743 characters), and it is not a report publication announcement since it contains substantive board meeting details rather than just a notice of report availability.
2021-07-29 Chinese
普莱柯2021年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2021 年半年度报告" which translates to "2021 Half-Year Report" or "Interim Report". It contains detailed financial data, management discussion and analysis, company information, financial indicators, and operational details for the first half of 2021. The length is substantial (15,000 characters), and it includes actual financial statements and substantive financial data. The content matches the characteristics of an Interim / Quarterly Report (IR) rather than a brief announcement or a full annual report. Therefore, the document is classified as an Interim / Quarterly Report (IR). H1 2021
2021-07-29 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.